Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts

Published:2003-03 Issue:3 Volume:51 Page:247-255
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Feng Ningping,Jin Hongnan,Wang Ming,Du Caigan,Wright Jim A.,Young Aiping H.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-002-0559-7.pdf

Reference40 articles.

1. Alter CI (1996) Palliative and supportive care of patients with pancreatic cancer. Semin Oncol 23:229

2. Warshaw AL, Castillo CFD (1992) Pancreatic carcinoma. New Engl J Med 326:455

3. Conton KC, Klimstra DS, Brennan MF (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Ann Surg 223:273

4. Schnall SF, MacDonald JS (1996) Chemotherapy of adenocarcinoma of pancreas. Semin Oncol 23:220

5. Regine WF, John WJ, Mohiuddin M (1997) Current and emerging treatment for pancreatic cancer. Drugs Aging 11:285

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic cancer therapy with a novel pump for controlled drug release;Oncology Reports;2009-12-28

2. IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo;Cancer Immunology, Immunotherapy;2009-12-13

3. Biological Approaches to Therapy of Pancreatic Cancer;Pancreatology;2008-10

4. Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors;Cancer Immunology, Immunotherapy;2008-03-20

5. Virulizin®, a novel immunotherapy agent, stimulates TNFα expression in monocytes/macrophages in vitro and in vivo;International Immunopharmacology;2007-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3